NeoGenomics is trading 4.89% higher at $18.65, likely amid broad risk-on sentiment as rate-hike concerns eased.
- September payrolls came in at 29,000, below expectations, while unemployment edged up to 4.2%.
- Reuters reported U.S. stock futures advanced as Treasury yields retreated and rate-increase odds fell.
- No clear company-specific announcement explaining the October 2 move surfaced; the latest listed company press release was its September 1 conference participation notice.